VISCERAL FAT INDEX INFORMS RISK OF MEDICALLY REFRACTORY IBD AND NEED FOR SURGERY IN PATIENTS STARTING ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY

被引：0
|
作者：
Gu, Phillip
Chhabra, Avneesh
Chhittajallu, Punya
Chang, Christopher
Mendez, Denisse
Gilman, Andrew
Fudman, David
Xi, Yin
Feagins, Linda
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2021年 / 27卷
关键词：
D O I：
10.1093/ibd/izaa347.112
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [1] VISCERAL FAT INDEX INFORMS RISK OF MEDICALLY REFRACTORY IBD AND NEED FOR SURGERY IN PATIENTS STARTING ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY
    Gu, Phillip
    Chhabra, Avneesh
    Chhittajallu, Punya
    Chang, Christopher
    Mendez, Denisse
    Gilman, Andrew
    Fudman, David
    Xi, Yin
    Feagins, Linda
    GASTROENTEROLOGY, 2021, 160 (03) : S64 - S64
  • [2] VISCERAL FAT INDEX INFORMS RISK OF MEDICALLY REFRACTORY IBD AND NEED FOR SURGERY IN PATIENTS STARTING ANTI-TUMOR NECROSIS (TNF) THERAPY
    Gu, Phillip
    Chhabra, Avneesh
    Chittajallu, Punya
    Chang, Christopher
    Mendez, Denisse
    Gilman, Andrew J.
    Fudman, David
    Xi, Yin
    Feagins, Linda A.
    GASTROENTEROLOGY, 2021, 160 (06) : S47 - S47
  • [3] VISCERAL ADIPOSE TISSUE INFLUENCES ANTI-TUMOR NECROSIS FACTOR (TNF) TREATMENT RESPONSE IN IBD
    Gu, Phillip
    Chhabra, Avneesh
    Chhittajallu, Punya
    Chang, Christopher
    Mendez, Denisse
    Gilman, Andrew
    Fudman, David
    Xi, Yin
    Feagins, Linda
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S46 - S47
  • [4] VISCERAL ADIPOSE TISSUE INFLUENCES ANTI-TUMOR NECROSIS FACTOR (TNF) TREATMENT RESPONSE IN IBD
    Gu, Phillip
    Chhabra, Avneesh
    Chittajallu, Punya
    Chang, Christopher
    Mendez, Denisse
    Gilman, Andrew J.
    Fudman, David
    Xi, Yin
    Feagins, Linda A.
    GASTROENTEROLOGY, 2021, 160 (06) : S42 - S43
  • [5] VISCERAL ADIPOSE TISSUE INFLUENCES ANTI-TUMOR NECROSIS FACTOR (TNF) TREATMENT RESPONSE IN IBD
    Gu, Phillip
    Chhabra, Avneesh
    Chhittajallu, Punya
    Chang, Christopher
    Mendez, Denisse
    Gilman, Andrew
    Fudman, David
    Xi, Yin
    Feagins, Linda
    GASTROENTEROLOGY, 2021, 160 (03) : S63 - S63
  • [6] Cutaneous manifestations of anti-tumor necrosis factor (anti-TNF) therapy in patients with inflammatory bowel disease (IBD): A case series
    Peer, F. C.
    Subramaniam, K.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 108 - 108
  • [7] Biological therapy in IBD -: Anti-tumor necrosis factor-alpha and others
    Schölmerich, J
    Huber, G
    DIGESTIVE DISEASES, 2003, 21 (02) : 180 - 191
  • [8] Anti-Tumor Necrosis Factor Therapy and Cancer Risk in Patients With Autoimmune Disorders
    Onel, Karen B.
    Onel, Kenan
    ARTHRITIS CARE & RESEARCH, 2010, 62 (07) : 1024 - 1028
  • [9] Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy
    Gu, Phillip
    Chhabra, Avneesh
    Chittajallu, Punya
    Chang, Christopher
    Mendez, Denisse
    Gilman, Andrew
    Fudman, David, I
    Xi, Yin
    Feagins, Linda A.
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (05) : 657 - 666
  • [10] Risk of Nocardial Infections With Anti-tumor Necrosis Factor Therapy
    Ali, Tauseef
    Chakraburtty, Amarsha
    Mahmood, Sultan
    Bronze, Michael S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (02): : 166 - 168
12345